Table 1
Predicted five-year relative survival ratios (RSR), by type of cancer and conditional on having survived up to five years, Canada excluding Quebec, 2004 to 2006

Cancer type RSR conditional on surviving (years)
0 1 2 3 4 5
  %
Thyroid 98 100 100 100 99 99
Prostate 96 97 98 99 99 99
Testis 95 98 99 99 100 100
Skin melanoma 90 92 94 96 97 98
Breast 88 89 90 91 92 93
Corpus uteri 85 90 94 96 98 98
Hodgkin lymphoma 85 92 93 94 94 95
Chronic lymphocytic leukemia (CLL) 77 80 79 78 79 78
Cervix uteri 73 82 87 92 94 96
Bladder (including in situ) 73 83 88 90 93 94
Kidney and renal pelvis 67 83 88 91 92 94
Soft tissue 65 79 86 90 92 93
Larynx 64 72 78 81 80 83
Rectum 64 73 79 84 90 93
Colon 63 77 85 90 94 97
Non-Hodgkin lymphoma 63 78 82 83 84 85
Oral (buccal cavity and pharynx) 63 74 82 86 88 88
Ovary 42 53 61 69 76 82
Multiple myeloma 37 45 47 51 55 60
Leukemia (excluding CLL) 34 65 77 78 88 90
Stomach 24 49 68 80 87 92
Brain 23 47 65 71 75 78
Liver 18 42 55 67 74 82
Lung and bronchus 16 37 54 65 71 75
Esophagus 13 34 56 69 77 83
Pancreas 6 28 54 68 79 88
standard error of 3.0% or more; no estimates have standard errors of 3.3% or more
Source: Canadian Cancer Registry, Statistics Canada and provincial/territorial cancer registries.